U.S. Tissue Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Technology & Product (IHC, Primary & Special Staining), By Application (Breast Cancer, NSCLC), And Segment Forecasts

Market Segmentation

U.S. Tissue Diagnostics Technology & Product Outlook (Revenue, USD Million, 2018 - 2030)
- Immunohistochemistry
  - Instruments
    - Slide Staining Systems
    - Tissue Microarrays
    - Tissue Processing Systems
    - Slide Scanners
    - Other Products
  - Consumables
    - Reagents
    - Antibodies
    - Kits
- In situ Hybridization
  - Instruments
  - Consumables
  - Software
- Primary & Special Staining
  - H&E Staining
  - Special Staining
- Digital Pathology & Workflow
  - Whole Slide Imaging
  - Image Analysis Informatics
  - Information Management System Storage & Communication
- Anatomic Pathology
  - Instruments
    - Microtomes & Cryostat Microtomes
    - Tissue Processors
    - Automatic Strainers
    - Other Products
  - Consumables
    - Reagents & Antibodies
    - Probes & Kits
    - Others
U.S. Tissue Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Non-Small Cell Lung Cancer
- Prostate Cancer
- Other Cancers
- Gastric Cancer
U.S. Tissue Diagnostics End Use Outlook (Revenue, USD Million; 2018 - 2030)
- Hospitals
- Research Laboratories
- Pharmaceutical Organizations
- CRO

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments